To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Vol:5 Issue:3 Number:2 ISSN#:2563-559X
OE Original

Platelet-rich Plasma (PRP) Versus Corticosteroid Injection for Painful Shoulder Conditions: Powered by OE M.I.N.D.

Authored By: Yaping Chang, Steve Phillips, Meng Zhu, Aiden Scholey, Mohit Bhandari On Behalf of OrthoEvidence

March 14, 2022

How to Cite

OrthoEvidence. Platelet-rich Plasma (PRP) Versus Corticosteroid Injection for Painful Shoulder Conditions: Powered by OE M.I.N.D.. OE Original. 2022;5(3):2. Available from: https://myorthoevidence.com/Blog/Show/173

Shoulder pain affects 1 in 4 people and is associated with impared life quality and function in work and household activities (Luime et al., 2004). Lifetime prevalence of shoulder pain ranges from 7% to 67% and for individuals whose work involves more upper limb activity and whose age is over 50, the prevalence is even higher, up to 78% (Luime et al., 2004; Hodgetts et al., 2021). Common conditions associated with pain and dysfunction in the shoulder include rotator cuff tears or other types of injuries, frozen shoulder, bursitis, tendinitis, impingement and osteoarthritis, etc. (Lewis, 2009) Conservative strategies including...
OE OriginalPreview Image

Please Login or Join to leave comments.